Abstract
The goals of this talk are to (1) review the source strength specification quantities and NIST standards employed for Pd-103 and I-125 interstitial brachytherapy sources; (2) review the role played by Monte Carlo simulation in the clinical dosimetry of these sources; and (3) describe clinical implementation of dosimetry and source strength standards, with emphasis on selection of prescribed dose and published AAPM guidance.
| Original language | English |
|---|---|
| Pages (from-to) | 21-24 |
| Number of pages | 4 |
| Journal | Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings |
| Volume | 1 |
| State | Published - Dec 1 2000 |
| Event | 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Chicago, IL, United States Duration: Jul 23 2000 → Jul 28 2000 |
Keywords
- Brachytherapy
- Dosimetry
- I-125
- Monte Carlo simulation
- Pd-103
- Source strength